-
MY33-3
2025-08-16
-
17-Hydroxyprogesterone
2025-08-15
-
Telithromycin
2025-08-15
-
HHS-0701
2025-08-14
-
Pseudothymidine
2025-08-14
-
Bropirimine
2025-08-13
-
5-MOM-UTP
2025-08-13
-
S 32826
2025-08-12
-
Anti-VEGFR1FLT1 Antibody (Abbott patent anti-Flt1)
2025-08-11
-
NSC 625987
2025-08-08
-
MPI-0479605
2025-08-08
-
Lathyrol
2025-08-07
-
Inolitazone dihydrochloride
2025-08-07
-
Ilimaquinone
2025-08-06
-
GDC-0879
2025-08-06